Fluorogenic gemcitabine based light up sensor for serum albumin detection in complex biological matrices.

Colloids Surf B Biointerfaces

Laser & Plasma Technology Division, Bhabha Atomic Research Centre, Mumbai 400085, India. Electronic address:

Published: December 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Herein we report fluorogenic derivative of gemcitabine (GEM-DNS), synthesized from gemcitabine hydrochloride and dansyl chloride in a single step. Owing to its large stoke shift of ∼200 nm and intriguing photophysical properties, the said dye has been utilized to estimate albumin concentration in complex bio-media such as human urine and blood serum. High sensitivity and selectivity towards albumin make the aforementioned dye a powerful diagnostic tool to detect ailments such as liver cirrhosis, diabetes, hypertension etc.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.colsurfb.2022.112865DOI Listing

Publication Analysis

Top Keywords

fluorogenic gemcitabine
4
gemcitabine based
4
based light
4
light sensor
4
sensor serum
4
serum albumin
4
albumin detection
4
detection complex
4
complex biological
4
biological matrices
4

Similar Publications

Fluorogenic gemcitabine based light up sensor for serum albumin detection in complex biological matrices.

Colloids Surf B Biointerfaces

December 2022

Laser & Plasma Technology Division, Bhabha Atomic Research Centre, Mumbai 400085, India. Electronic address:

Herein we report fluorogenic derivative of gemcitabine (GEM-DNS), synthesized from gemcitabine hydrochloride and dansyl chloride in a single step. Owing to its large stoke shift of ∼200 nm and intriguing photophysical properties, the said dye has been utilized to estimate albumin concentration in complex bio-media such as human urine and blood serum. High sensitivity and selectivity towards albumin make the aforementioned dye a powerful diagnostic tool to detect ailments such as liver cirrhosis, diabetes, hypertension etc.

View Article and Find Full Text PDF

Background: Aspirin (acetylsalicylic acid) and celecoxib have been used as potential anti-cancer therapies. Aspirin exerts its therapeutic effect in both cyclooxygenase (COX)-dependent and -independent pathways to reduce tumor growth and disable tumorigenesis. Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, reduces factors that cause inflammation and pain.

View Article and Find Full Text PDF

Evaluation of a GSH-targeting prodrug via a sulfonamide-induced "integrative" platform for selective cancer therapy.

Analyst

July 2020

The College of Chemistry and Chemical Engineering, Hexi University, Zhangye City 734000, Gansu Province, P. R. China.

A sulfonamide-appended gemcitabine prodrug was newly produced. The prodrug was shown to efficiently distinguish GSH from cysteine and homocysteine. Upon reaction of this prodrug with GSH, which is relatively abundant in tumor cells, sulfonyl group cleavage occurred as well as active release of the drug GMC and a concomitant increase in the innate fluorescence intensity.

View Article and Find Full Text PDF

Anthracyclines, proteasome activity and multi-drug-resistance.

BMC Cancer

September 2005

Department of Neurology, Bürgerhospital, Tunzhofer Str. 14-16, 70191 Stuttgart, Germany.

Background: P-glycoprotein is responsible for the ATP-dependent export of certain structurally unrelated compounds including many chemotherapeutic drugs. Amplification of P-glycoprotein activity can result in multi-drug resistance and is a common cause of chemotherapy treatment failure. Therefore, there is an ongoing search for inhibitors of P-glycoprotein.

View Article and Find Full Text PDF